BRIEF-Esperion Therapeutics announces positive top line phase 2b results for ETC-1002

* Esperion Therapeutics Announces Positive Top Line phase 2b results for ETC-1002
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.